Ameriprise’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.7M Sell
636,453
-60,372
-9% -$1.3M ﹤0.01% 1588
2025
Q1
$11.6M Sell
696,825
-188,045
-21% -$3.12M ﹤0.01% 1662
2024
Q4
$16.2M Buy
884,870
+120,996
+16% +$2.22M ﹤0.01% 1473
2024
Q3
$11.7M Buy
763,874
+21,228
+3% +$326K ﹤0.01% 1654
2024
Q2
$12.1M Buy
742,646
+463
+0.1% +$7.52K ﹤0.01% 1593
2024
Q1
$13.7M Buy
742,183
+95,071
+15% +$1.76M ﹤0.01% 1532
2023
Q4
$20.3M Buy
647,112
+67,605
+12% +$2.12M 0.01% 1270
2023
Q3
$12.1M Buy
579,507
+11,461
+2% +$239K ﹤0.01% 1548
2023
Q2
$13.6M Sell
568,046
-12,429
-2% -$298K ﹤0.01% 1527
2023
Q1
$10.9M Buy
580,475
+57,179
+11% +$1.08M ﹤0.01% 1705
2022
Q4
$8.33M Sell
523,296
-406,511
-44% -$6.47M ﹤0.01% 1897
2022
Q3
$15.2M Sell
929,807
-15,253
-2% -$249K 0.01% 1366
2022
Q2
$13.3M Sell
945,060
-134,481
-12% -$1.9M ﹤0.01% 1504
2022
Q1
$26.1M Sell
1,079,541
-78,757
-7% -$1.91M 0.01% 1157
2021
Q4
$27M Buy
1,158,298
+29,518
+3% +$689K 0.01% 1191
2021
Q3
$18.8M Sell
1,128,780
-169,958
-13% -$2.82M 0.01% 1316
2021
Q2
$31.7M Sell
1,298,738
-1,135,313
-47% -$27.7M 0.01% 1033
2021
Q1
$62.8M Buy
2,434,051
+1,168,541
+92% +$30.1M 0.02% 680
2020
Q4
$67.7M Buy
1,265,510
+49,503
+4% +$2.65M 0.02% 606
2020
Q3
$50.2M Sell
1,216,007
-950,967
-44% -$39.2M 0.02% 640
2020
Q2
$105M Buy
2,166,974
+574,958
+36% +$27.9M 0.05% 379
2020
Q1
$67.3M Buy
1,592,016
+713,916
+81% +$30.2M 0.04% 452
2019
Q4
$37.6M Sell
878,100
-122,394
-12% -$5.24M 0.02% 830
2019
Q3
$36M Buy
1,000,494
+530,622
+113% +$19.1M 0.02% 810
2019
Q2
$12.6M Sell
469,872
-62,797
-12% -$1.68M 0.01% 1551
2019
Q1
$14.3M Buy
532,669
+168,178
+46% +$4.52M 0.01% 1391
2018
Q4
$5.89M Sell
364,491
-469
-0.1% -$7.58K ﹤0.01% 2015
2018
Q3
$7.56M Sell
364,960
-577,268
-61% -$12M ﹤0.01% 2077
2018
Q2
$14.4M Buy
942,228
+70,908
+8% +$1.08M 0.01% 1433
2018
Q1
$19.6M Buy
871,320
+25,380
+3% +$570K 0.01% 1132
2017
Q4
$25.5M Sell
845,940
-46,066
-5% -$1.39M 0.01% 928
2017
Q3
$33.6M Sell
892,006
-125,546
-12% -$4.73M 0.02% 722
2017
Q2
$28.4M Buy
1,017,552
+134,830
+15% +$3.76M 0.01% 798
2017
Q1
$30.3M Buy
882,722
+506,605
+135% +$17.4M 0.02% 754
2016
Q4
$10.8M Buy
376,117
+66,536
+21% +$1.92M 0.01% 1463
2016
Q3
$9.85M Sell
309,581
-120,384
-28% -$3.83M 0.01% 1465
2016
Q2
$14M Sell
429,965
-12,353
-3% -$401K 0.01% 1146
2016
Q1
$12.4M Buy
442,318
+204,148
+86% +$5.71M 0.01% 1258
2015
Q4
$8.49M Buy
238,170
+129,075
+118% +$4.6M 0.01% 1573
2015
Q3
$3.61M Buy
109,095
+22,315
+26% +$738K ﹤0.01% 2232
2015
Q2
$3.63M Sell
86,780
-3,727
-4% -$156K ﹤0.01% 2347
2015
Q1
$2.95M Sell
90,507
-229,014
-72% -$7.46M ﹤0.01% 2390
2014
Q4
$10.1M Sell
319,521
-61,260
-16% -$1.94M 0.01% 1488
2014
Q3
$9.43M Sell
380,781
-17,663
-4% -$437K 0.01% 1520
2014
Q2
$9M Sell
398,444
-154,886
-28% -$3.5M 0.01% 1634
2014
Q1
$13.5M Buy
553,330
+301,548
+120% +$7.34M 0.01% 1283
2013
Q4
$6.29M Sell
251,782
-15,266
-6% -$381K ﹤0.01% 1847
2013
Q3
$7.34M Sell
267,048
-23,737
-8% -$652K ﹤0.01% 1679
2013
Q2
$5.28M Buy
+290,785
New +$5.28M ﹤0.01% 1858